(Q33412455)

26 July 2017

Weekly low-dose adriamycin in hormone-resistant metastatic cancer of the prostate (English)

1 reference

26 July 2017

1 reference

1

Fosså SD

1 reference

26 July 2017

Urnes T

2

1 reference

PubMed ID

2438753

26 July 2017

Kaalhus O

series ordinal

3

1 reference

PubMed ID

2438753

26 July 2017

language of work or name

1 reference

1 January 1987

1 reference

Scandinavian Journal of Urology and Nephrology

26 July 2017

1 reference

26 July 2017

21

1 reference

26 July 2017

1

1 reference

26 July 2017

13-16

1 reference

Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer. A randomized trial

26 July 2017

1 reference

https://api.crossref.org/works/10.3109%2F00365598709180283

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365598709180283

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365598709180283

Low-dose Doxorubicin in the Management of Advanced Carcinoma of the Prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00365598709180283

10.3109/00365598709180283

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference

PubMed ID

2438753